Predict your next investment

HEALTHCARE | Biotechnology

See what CB Insights has to offer

Founded Year



Acquired | Acquired

About Fiomi Diagnostics

Fiomi Diagnostics provides forecast technology that enables picomolar sensitivity for whole-blood In Vitro diagnostic immunoassays. The technology is based on a microstructured plastic chip which provides a flow of fluid in lateral flow assays and an fluorescence detection system providing quantitative test results.In March 2012, Fiomi Diagnostics was acquired by Trinity Biotech. The valuation of Fiomi Diagnostics was undisclosed. Other terms of the deal were not released.

Fiomi Diagnostics Headquarter Location

Dag Hammarskjoldsv 52A

SE-752 37,


+46 18 56 08 90

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.